CORRIE KILLINGSWORTH: Open Payments
NPI 1356949077 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,889 in 158 payments from 46 companies in 2025. Trend: 2023 $3,155 · 2024 $3,670 · 2025 $3,889
Food & beverage: $3,889
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $318 |
| PFIZER INC. | 11 | $232 |
| Gilead Sciences, Inc. | 7 | $228 |
| Novartis Pharmaceuticals Corporation | 10 | $195 |
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| Daiichi Sankyo Inc. | 6 | $176 |
| Incyte Corporation | 7 | $175 |
| Celgene Corporation | 6 | $156 |
| ABBVIE INC. | 6 | $149 |
| Pharmacosmos Therapeutics Inc. | 2 | $145 |
Products named: KEYTRUDA, ENHERTU, REBLOZYL, COSELA, OPDIVO, BRUKINSA, Trodelvy, Vonjo.
Industry payments across FL — which companies pay providers there.
